| Ticker Details |
|
Bionano Genomics, Inc.
|
| IPO Date: |
September 21, 2018 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$14.23M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 4.48%
|
| Avg Daily Range (30 D): |
$0.03 | 2.41%
|
| Avg Daily Range (90 D): |
$0.04 | 2.91%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
6.86M |
| Avg Daily Volume (30 D): |
.14M |
| Avg Daily Volume (90 D): |
.28M |
| Trade Size |
| Avg Trade Size (Sh.): |
330 |
| Avg Trade Size (Sh.) (30 D): |
191 |
| Avg Trade Size (Sh.) (90 D): |
215 |
| Institutional Trades |
| Total Institutional Trades: |
870 |
| Avg Institutional Trade: |
$1.76M |
| Avg Institutional Trade (30 D): |
$.7M |
| Avg Institutional Trade (90 D): |
$.7M |
| Avg Institutional Trade Volume: |
M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.59M |
| Avg Closing Trade (30 D): |
$.7M |
| Avg Closing Trade (90 D): |
$.7M |
| Avg Closing Volume: |
.98K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-4.37
|
$-.76
|
$-.03
|
|
Diluted EPS
|
$-4.37
|
$-.76
|
$-.03
|
|
Revenue
|
$28.74M
|
$6.69M
|
$7.95M
|
|
Gross Profit
|
$13.5M
|
$3.25M
|
$3.4M
|
|
Net Income / Loss
|
$-31.6M
|
$-8.3M
|
$-7.93M
|
|
Operating Income / Loss
|
$-32.77M
|
$-7.9M
|
$-8.54M
|
|
Cost of Revenue
|
$15.24M
|
$3.44M
|
$4.55M
|
|
Net Cash Flow
|
$1.29M
|
$.4M
|
$1.44M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 27, 2025
|
1:60
|
|
Aug 07, 2023
|
1:10
|
|
|
|